Gut bacteria may hold key to better heart surgery recovery
NCT ID NCT07497932
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study is testing whether giving probiotics after heart surgery can improve recovery by changing the bacteria in the gut. Researchers will measure certain chemicals in the blood that come from gut bacteria. The trial involves 30 adults scheduled for heart surgery, who will receive either a probiotic or a placebo alongside standard care.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- probiotic supplementation
- What this could lead to
- If it works, this could point toward a simple way to improve recovery after heart surgery by supporting gut health.
- What could go wrong
- This is a very small, early-stage study focused on measuring changes in the body, not on proving a treatment works. The results may not lead to any new recommendations.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 30 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Mar 2026
- Expected to finish
-
Dec 2026
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
50 to 80 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Scheduled to undergo cardiovascular surgery * Completed preoperative clinical and imaging evaluations * Willing to provide informed consent * Willing to receive potential probiotic supplementation Exclusion Criteria: * Use of antibiotics, probiotics, or other treatments affecting gut microbiota within 4 weeks * History of major gastrointestinal disease
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Cardiovascular disease are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Fu Jen Catholic University Hospital, Fu Jen Catholic University
RECRUITINGNew Taipei City, 24352, Taiwan
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can AI-Tailored heat warnings shield chronic disease patients from dangerous temperatures?
- Can biomarkers flag kidney risk before heart surgery?
- Can AI spot kidney damage before it strikes after heart surgery?
- Can calming inflammation shield the heart?
- Could artery disease drain the body's repair cells?
- Can hidden blood mutations ignite heart disease?